相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Effect of overexpression of pparγ on the healing process of corneal alkali burn in mice
Shizuya Saika et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Agonists of peroxisome proliferators-activated receptors (PPAR) α, β/δ or γ reduce transforming growth factor (TGF)-β-induced proteoglycans' production in chondrocytes
P. E. Poleni et al.
OSTEOARTHRITIS AND CARTILAGE (2007)
Pathogenetic pathways and novel pharmaco therapeutic targets in idiopathic pulmonary fibrosis
Katerma M. Antomou et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future research
Pelagia G. Tsoutsou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Troglitazone inhibits synthesis of transforming growth factor-β1 and reduces matrix production in human peritoneal mesothelial cells
Youming Peng et al.
NEPHROLOGY (2006)
PPARγ agonists prevent TGFβ1 Smad3-signaling in human hepatic stellate cells
Caiyan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
PPARs and other nuclear receptors in inflammation
Giovanni Rizzo et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition
Du-Hyong Cho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity
Kuy-Sook Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARγ agonists
Amar G. Chittiboyina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics
Danielle G. Lemay et al.
JOURNAL OF LIPID RESEARCH (2006)
Structure-based drug design of a novel family of PPARγ partial agonists:: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities
IL Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats
J Weissgarten et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Involvement of PPAR nuclear receptors in tissue injury and wound repair
L Michalik et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Rosiglitazone suppresses human lung carcinoma cell growth through PPAR-γ-dependent and PPARγ-independent signal pathways
SW Han et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Proteomic study of plasma proteins in pregnant women with asthma
VE Murphy et al.
RESPIROLOGY (2006)
The pathophysiological function of peroxisome proliferator-activated receptor-γ lung-related diseases -: art. no. 102
THW Huang et al.
RESPIRATORY RESEARCH (2005)
Autoimmunity and interstitial lung disease
SK Jindal et al.
CURRENT OPINION IN PULMONARY MEDICINE (2005)
Epstein-Barr-virus-induced interstitial lung disease
K Marzouk et al.
CURRENT OPINION IN PULMONARY MEDICINE (2005)
Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle
H García-Rivello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
A Grubstein et al.
RESPIRATORY MEDICINE (2005)
Histopathologic pattern and clinical features of rheumatoid arthritis associated interstitial lung disease
HK Lee et al.
CHEST (2005)
PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production:: implications for therapy of lung fibrosis
HA Burgess et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
CD40 engagement prevents peroxisome proliferator-activated receptor γ agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-κB-dependent mechanism
DM Ray et al.
JOURNAL OF IMMUNOLOGY (2005)
Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice
DJ van Westerloo et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
Exploring the binding site structure of the PPARγ ligand-binding domain by computational solvent mapping
SH Sheu et al.
BIOCHEMISTRY (2005)
Mechanisms and mediators of pulmonary fibrosis
MP Keane et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2005)
Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury
T Genovese et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
VS Rajkumar et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis
M Gharaee-Kermani et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention
V Mehta
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Peroxisome proliferator-activated receptor γ is expressed in airways and inhibits features of airway remodeling in a mouse asthma model
K Honda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Disruption of transforming growth factor β signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor γ
AK Ghosh et al.
ARTHRITIS AND RHEUMATISM (2004)
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis
SJ Forbes et al.
GASTROENTEROLOGY (2004)
Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands
RC Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
PPARγ ligands, 15-deoxy-Δ12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms
JE Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni et al.
ONCOGENE (2004)
CCAAT/enhancer-binding protein β isoforms and the regulation of α-smooth muscle actin gene expression by IL-1β
B Hu et al.
JOURNAL OF IMMUNOLOGY (2004)
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy
VJ Thannickal et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARγ in normal mouse skin keratinocytes
GB He et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells
BL Guo et al.
DIABETES (2004)
Mechanisms of pulmonary fibrosis
VJ Thannickal et al.
ANNUAL REVIEW OF MEDICINE (2004)
Differential effects of peroxisome proliferator activated receptor-γ (PPARγ) ligands in proximal tubular cells:: Thiazolidinediones are partial PPARγ agonists
RS Chana et al.
KIDNEY INTERNATIONAL (2004)
c-Fos-driven transcriptional activation of transforming growth factor β1:: inhibition of high glucose-induced promoter activity by thiazolidinediones
C Weigert et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase
VJ Thannickal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
A Galli et al.
GASTROENTEROLOGY (2002)
Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation
F Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro
RE Routh et al.
KIDNEY INTERNATIONAL (2002)
Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride
K Kon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells
A Masamune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes
GF Davies et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Medical progress: Idiopathic pulmonary fibrosis.
TJ Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
T Miyahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pleuropulmonary manifestations of systemic lupus erythematosus
MP Keane et al.
THORAX (2000)
分享论文
